A Change is Gonna Come: How Will the New HHS and FDA Affect Pharmaceutical and Medical Device Companies?

Cathy Burgess was a speaker during this audioconference sponsored by Thompson Interactive. The following topics were covered during the program.

• Selection of Tom Daschle as HHS Secretary. What does this say about the Administration’s view of pharmaceutical and medical device companies?
• Selection of CMS Administrator and FDA Commissioner. When will they be selected? What is the significance to industry?
• Will President Obama’s Administration reverse preemption?
• What other current FDA principles are likely to change?
• What is the likelihood of the enactment of broad health care and/or Medicare reform in 2009?
• How could President Obama’s expanded access plan impact